UK government
ABPI Issues Recommendations for UK to Prepare for New Cell, Gene Therapies
The trade group said the UK should prepare for therapies that aim to treat larger patient populations, which could necessitate new payment approaches.
UK's MHRA Approves Astellas' Vyloy for CLDN18.2-Positive Gastric Cancer
The approval is based on two trials in which Vyloy plus chemo bested chemo and placebo in advanced CLDN18.2-positive, HER2-negative gastric cancer.
GenSight Biologics to File UK Application for LHON Gene Therapy, Mulls 'Strategic Opportunities'
With a cash runway into February 2024, the firm said it is considering a possible merger, acquisition, or licensing deal.
UK Pilot Project to Develop Antisense Oligonucleotides for Children With Ultra-Rare Brain Disorders
The pilot, part of a new government-funded program, will test an end-to-end pathway covering diagnosis, individual therapy design and manufacturing, and treatment.
NHS Unveils New Cell and Gene Manufacturing Facility to Advance Research, Drug Development
The facility will provide researchers with viral vectors and plasmids to make cell and gene therapies at a clinical scale, reducing reliance on suppliers abroad.